{"nct_id":"NCT03169738","title":"QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors","status":"WITHDRAWN","status_verified_date":"2017-10","start_date":"2018-02","start_date_type":"ESTIMATED","primary_completion_date":"2019-01","primary_completion_date_type":"ESTIMATED","completion_date":"2021-12-28","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["IBRX"]}